Company intelligence / Profile preview

Sanford Laboratories for Innovative Medicines

San Diego, California, United Statessanfordlabs.org ↗

Ownership: Private
Employees: ~30
Development stage: Preclinical

Overview

Sanford Laboratories for Innovative Medicines is an independent, not-for-profit biomedical research organization focused on advancing next-generation RNA technologies and therapies. The organization serves as a collaborative hub to drive innovation in precision medicines. There are no disclosed clinical results or late-stage development programs as of the latest filings.[1][3][5]

Therapeutic areas: Oncology
Modalities: RNA therapeutics (next-generation RNA technologies and therapies)[1][5]
Industry: Academic Hospital/University/Research

Partnerships

Collaborations with academic institutions such as UC San Diego (via Chief Scientist Gene Yeo's affiliations)[6].

Beyond the preview

Go deeper on Sanford Laboratories for Innovative Medicines.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sanford Laboratories for Innovative Medicines.

Explore the full profile